Research location
Manchester
Greater Manchester, United Kingdom
Advertisement
Research activity in Manchester
Greater Manchester, United KingdomCureCurrent currently publishes aggregate city-level research activity for this location: 89 trials and 162 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Manchester
89 linked trials · page 1 of 2CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) AmyloidosisNCT07207811 · 2025-10-02 · 1 site observation
RECRUITING
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)NCT06961214 · 2025-06-23 · 1 site observation
RECRUITING
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe AsthmaNCT06977581 · 2025-05-20 · 1 site observation
RECRUITING
A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid TumorsNCT06914128 · 2025-03-21 · 1 site observation
RECRUITING
Chronic Radiation Induced Bowel Toxicity StudyNCT06640959 · 2024-11-19 · 1 site observation
RECRUITING
HIV and Changes in the Gut Microbiome After Changes in Antiretroviral Therapy (ART)NCT06100211 · 2024-05-17 · 1 site observation
RECRUITING
Detecting EARLY Heart Failure in Greater ManchesterNCT05955456 · 2023-10-09 · 1 site observation
RECRUITING
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)NCT05489705 · 2022-08-16 · 1 site observation
RECRUITING
A Study of DB-1303/BNT323 vs Investigator's Choice Chemotherapy in HER2-Low, Hormone Receptor Positive Metastatic Breast Cancer (DYNASTY-Breast02)NCT06018337 · 2024-01-18 · 1 site observation
ACTIVE_NOT_RECRUITING
Diagnostic Accuracy Study for OWL-EVO1 as a Lung Cancer EVOC® Probe (Evolution Phase 2)NCT06193239 · 2023-10-05 · 1 site observation
COMPLETED
Improving Access and Recruitment to Clinical Trials for Lung Cancer PatientsNCT05888584 · 2023-07-01 · 1 site observation
COMPLETED
Role of Fasted Exercise on Improving Cardiometabolic HealthNCT05742373 · 2023-03-01 · 1 site observation
UNKNOWN
Breast CANcer Risk Assessment in Younger Women: BCAN-RAYNCT05305963 · 2023-01-31 · 1 site observation
UNKNOWN
A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma.NCT05763121 · 2023-01-30 · 4 site observations
TERMINATED
Remote Glucose Monitoring in Hospital SettingsNCT04797208 · 2023-01-09 · 1 site observation
UNKNOWN
SPL026 With or Without SSRIs in Participants With MDDNCT05553691 · 2022-12-13 · 1 site observation
COMPLETED
Service User and Staff Views on Digital Remote Monitoring for PsychosisNCT05670197 · 2022-11-01 · 1 site observation
COMPLETED
A First-in-human Study to Learn How Safe the Study Drug BAY3375968, an Anti-CCR8 Antibody, is, When Given Alone or in Combination With Pembrolizumab, How it Affects the Body, How it Moves Into, Through, and Out of the Body, and to Find the Best Dose in Participants With Advanced Solid TumorsNCT05537740 · 2022-10-11 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Learn About the Safety of Diranersen (BIIB080) Injections and Whether They Can Improve Symptoms of Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD Dementia Between 50 to 80 Years of AgeNCT05399888 · 2022-08-24 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's DiseaseNCT05310071 · 2022-06-02 · 1 site observation
TERMINATED
FH-Risk 2.0: Updating Breast Cancer Risk EstimatesNCT05082740 · 2022-03-01 · 1 site observation
COMPLETED
Manchester Intermittent and Daily Diet Type 1 Diabetes App Study (MIDDAS-Type 1)NCT04674384 · 2022-01-19 · 1 site observation
UNKNOWN
Combination Study of RMC-4630 and Sotorasib for NSCLC Subjects With KRASG12C Mutation After Failure of Prior Standard TherapiesNCT05054725 · 2021-12-30 · 1 site observation
COMPLETED
A Study to Assess Efficacy and Safety of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of SchizophreniaNCT05145413 · 2021-11-12 · 1 site observation
COMPLETED
Safety and Dose Ranging Study for OWL-EVO1 as a Lung Cancer EVOC® Probe (Evolution)NCT05510674 · 2021-07-06 · 1 site observation
COMPLETED
Study of CB307 in Patients With Advanced and/or Metastatic PSMA-positive Tumours.NCT04839991 · 2021-06-08 · 1 site observation
UNKNOWN
PRECISion medicinE Across the Disease Continuum to Prevent and Treat Rheumatoid ArthritisNCT04482335 · 2021-05-15 · 1 site observation
UNKNOWN
Study in Healthy Participants and Participants With Moderate Atopic Dermatitis & Optionally, Moderate Psoriasis, and/or Mild AsthmaNCT04927195 · 2021-02-23 · 2 site observations
COMPLETED
PAveMenT: Palbociclib and Avelumab in Metastatic AR+ Triple Negative Breast CancerNCT04360941 · 2020-08-11 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Evaluate Safety and Tolerability of Aducanumab in Participants With Alzheimer's Disease Who Had Previously Participated in the Aducanumab Studies 221AD103, 221AD301, 221AD302 and 221AD205NCT04241068 · 2020-03-02 · 1 site observation
TERMINATED
Registry of Asthma Patients Initiating DUPIXENT®NCT04287621 · 2020-03-02 · 1 site observation
COMPLETED
Trans People Living With HIV Throughout EuropeNCT03922269 · 2019-10-11 · 1 site observation
COMPLETED
What Are the Benefits and Harms of Risk Stratified Screening in the NHS Breast Screening Programme: Study ProtocolNCT04359420 · 2019-08-01 · 1 site observation
COMPLETED
WORKWELL: Testing Work Advice for People With ArthritisNCT03942783 · 2019-03-22 · 1 site observation
COMPLETED
OUTREACH: Urine Analysis and Antihypertensive TreatmentNCT03293147 · 2018-12-18 · 1 site observation
COMPLETED
The CLiFF Study: Change in Liver Function and Fat in Pre-operative Chemotherapy for Colorectal Liver MetastasesNCT03562234 · 2018-10-22 · 1 site observation
UNKNOWN
DS-8201a Versus T-DM1 for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive, Unresectable and/or Metastatic Breast Cancer Previously Treated With Trastuzumab and Taxane [DESTINY-Breast03]NCT03529110 · 2018-08-09 · 1 site observation
COMPLETED
Study to Evaluate the Safety and Efficacy of Relamorelin in Participants With Diabetic Gastroparesis Study 02NCT03426345 · 2018-02-16 · 1 site observation
TERMINATED
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04NCT03383146 · 2018-02-01 · 1 site observation
TERMINATED
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 03NCT03420781 · 2018-01-24 · 1 site observation
TERMINATED
Proof of Concept Study to Investigate Etokimab (ANB020) Activity in Adult Participants With Severe Eosinophilic AsthmaNCT03469934 · 2017-11-14 · 1 site observation
COMPLETED
Interstitial Lung Disease Within a Lung Cancer ScreeningNCT04715347 · 2017-11-11 · 1 site observation
COMPLETED
Measuring Development of Brain Responses to Vocal Sounds in Babies of Mums With Mental IllnessNCT04350294 · 2017-09-01 · 1 site observation
UNKNOWN
Respiratory Distress Symptom Intervention (RDSI) TrialNCT03223805 · 2017-04-04 · 2 site observations
COMPLETED
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)NCT03071692 · 2017-03-23 · 2 site observations
TERMINATED
A Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease DementiaNCT02972658 · 2017-03-15 · 1 site observation
TERMINATED
The Efficacy and Safety of Pirfenidone in Patients With Heart Failure and Preserved Left Ventricular Ejection FractionNCT02932566 · 2017-03-02 · 1 site observation
COMPLETED
Pembrolizumab in Patients With Non-Small Cell Lung Cancer and a Performance Status 2NCT02733159 · 2017-01-04 · 1 site observation
COMPLETED
A 24-Month Study to Evaluate the Efficacy and Safety of Elenbecestat (E2609) in Participants With Early Alzheimer's DiseaseNCT02956486 · 2016-10-20 · 1 site observation
TERMINATED
SFX-01 in the Treatment and Evaluation of Metastatic Breast CancerNCT02970682 · 2016-10-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.